Registro:

Referencias:

• Allolio, B., Arlt, W., DHEA treatment: Myth or reality? (2002) Trends in Endocrinology and Metabolism, 13, pp. 288-294
• Arlt, W., Callies, F., van Vlijmen, J.C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Allolio, B., Dehydroepiandrosterone replacement in women with adrenal insufficiency (1999) New England Journal of Medicine, 341, pp. 1013-1020
• Del Punta, K., Charreau, E., Pignataro, O.P., Nitric oxide inhibits Leydig cell steroidogenesis (1996) Endocrinology, 137, pp. 5337-5343
• Diaz-Torga, G.S., Becu-Villalobos, D., Libertun, C., Ontogeny of angiotensin-induced prolactin release in vivo and in vitro in female and male rats (1994) Neuroendocrinology, 59, pp. 57-62
• Diaz-Torga, G.S., Gonzalez Iglesias, A., Achaval-Zaia, R., Libertun, C., Becu-Villalobos, D., Angiotensin II induced calcium mobilization and prolactin release in normal and hyperplastic pituitary cells (1998) American Journal of Physiology - Endocrinology and Metabolism, 274, pp. E534-E540
• Ebeling, P., Koivisto, V.A., Physiological importance of dehydroepiandrosterone (1994) Lancet, 343, pp. 1479-1481
• Freeman, M.E., Kanyicska, B., Lerant, A., Nagy, G., Prolactin: Structure, function, and regulation of secretion (2000) Physiological Reviews, 80, pp. 1523-1631
• Gobbe, P., Herchuelz, A., Effects of verapamil and nifedipine on gliclazide-induced increase in cytosolic free Ca2+ in pancreatic islet cells (1989) Journal of Endocrinological Investigation, 12, pp. 469-474
• Gonzalez Iglesias, A., Diaz-Torga, G., Piroli, G., Achaval-Zaia, R., De Nicola, A.F., Libertun, C., Becu-Villalobos, D., Bromocriptine restores angiotensin II response in pituitary hyperplasia (2000) Molecular and Cellular Endocrinology, 165, pp. 67-74
• Gonzalez Iglesias, A., Suérez, C., Feierstein, C., Diaz-Torga, G., Becu-Villalobos, D., Desensitization of angiotensin II: Effect on [Ca2+]i, inositol triphosphate, and prolactin in pituitary cells (2001) American Journal of Physiology - Endocrinology and Metabolism, 280, pp. E462-E470
• Grynkiewicz, G., Poenie, M., Tsien, R.Y., A new generation of Ca2+ indicators with greatly improved fluorescence properties (1985) Journal of Biological Chemistry, 260, pp. 3440-3450
• Hinson, J.P., Raven, P.W., DHEA deficiency syndrome: A new term for old age? (1999) Journal of Endocrinology, 163, pp. 1-5
• Knudsen, J.F., Costoff, A., Mahesh, V.B., Dehydroepiandrosterone induced polycystic ovaries and acyclicity in the rat (1975) Fertility and Sterility, 26, pp. 807-817
• Kroboth, P.D., Salek, F.S., Pittenger, A.L., Fabian, T.J., Frye, R.F., DHEA and DHEA-S: A review (1999) Journal of Clinical Pharmacology, 39, pp. 327-348
• Lachowicz, A., Rebas, E., Gender differences in steroid modulation of angiotensin II-induced protein kinase C activity in anterior pituitary of the rat (2002) Biochemical and Biophysical Research Communications, 294, pp. 95-100
• Legan, M., Kocijancic, A., Prezelj, J., Osredkar, J., Fisker, S., GH-IGF-I axis in non-obese women with functional hyperandrogenism (2002) Journal of Endocrinological Investigation, 25, pp. 691-695
• Lussier, B.T., French, M.B., Moor, B.C., Kraicer, J., Free intracellular Ca2+ concentration ([Ca2+]) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca2+ influx raises [Ca2+] (1991) Endocrinology, 128, pp. 570-582
• Maggiolini, M., Donze, O., Jeannin, E., Ando, S., Picard, D., Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha (1999) Cancer Research, 59, pp. 4864-4869
• Moreau, C., Rasolonjanahary, R., Zamora, A.J., Enjalbert, A., Kordon, C., Llorens-Cortes, C., Expression of angiotensin II receptor subtypes AT(1A) and AT(1B) in enriched fractions of dispersed rat pituitary cells (1997) Neuroendocrinology, 66, pp. 416-425
• Müller, E., Locatelli, V., Cocchi, D., Neuroendocrine control of growth hormone secretion (1999) Physiological Reviews, 79, pp. 511-607
• Poortman, J., Prenen, J.A.C., Schwarz, F., Thijssen, J.H.H., Interaction of delta-5 - Androstene-3 beta, 17 beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue (1975) Journal of Clinical Endocrinology and Metabolism, 40, pp. 373-379
• Rao, M.S., Subbarao, V., Yeldandi, A.V., Reddy, J.K., Hepatocarcinogenicity of dehydroepiandrosterone in the rat (1992) Cancer Research, 52, pp. 2977-2979
• Rose, K., Allan, A., Gauldie, S., Stapleton, G., Lorraine, D., Dott, K., Martin, C., Lathe, R., Neurosteroid hydroxylase CYP7B. Vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation (2001) Journal of Biological Chemistry, 276, pp. 23937-23944
• Shealy, C.N., A review of dehydroepiandrosterone (DHEA) (1995) Integrative Physiological and Behavioral Science, 30, pp. 308-313
• Suárez, C., García-Tornadú, I., Khalil, W., Becu-Villalobos, D., Dehydroepiandrosterone treatment attenuates estrogen induced pituitary hyperplasia (2002) Journal of Endocrinology, 174, pp. 447-454
• Suárez, C., Diaz-Torga, G., Gonzalez-Iglesias, A., Vela, J., Mladovan, A., Baldi, A., Becu-Villalobos, D., Angiotensin II phosphorylation of extracellular signal regulated kinases in rat anterior pituitary cells (2003) American Journal of Physiology - Endocrinology and Metabolism, 285, pp. E645-E653
• Svec, F., Porter, J., The actions of exogenous dehydroepiandrosterone in experimental animals and humans (1998) Proceedings of the Society of Experimental Biology and Medicine, 218, pp. 174-191

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------